Today: 10 June 2026
Marvell stock slips today as chips cool into year-end; MRVL traders eye Fed minutes and CES
30 December 2025
1 min read

Marvell stock slips today as chips cool into year-end; MRVL traders eye Fed minutes and CES

NEW YORK, December 29, 2025, 8:42 PM ET — Market closed

  • Marvell shares fell 0.6% to $85.76 as the chip sector turned mixed in late-year trading.
  • Nvidia and Broadcom slipped, while Intel rose after a filing showed Nvidia took a $5 billion stake.
  • Investors are watching Fed minutes, weekly jobless claims and Marvell’s CES-linked CEO appearance next.

Marvell Technology Inc (MRVL) shares fell 0.6% to $85.76 on Monday, with the Nasdaq-listed chipmaker trading between $84.21 and $86.09 as markets headed into the final trading days of the year.

Marvell supplies data infrastructure semiconductor solutions spanning the data center core to the network edge, and also develops chips tailored to specific customer designs for artificial intelligence and other networking-heavy workloads.

That mix leaves the stock sensitive to shifts in risk appetite around AI-linked hardware, especially when investors rebalance positions into year-end.

Semiconductors were mixed on the day. Nvidia fell about 1.2% and Broadcom slid 0.8%, while Intel rose 1.3%; the iShares Semiconductor ETF eased 0.2%.

Intel remained in focus after the company said in a filing that Nvidia had purchased Intel shares worth $5 billion, carrying out a transaction announced in September.

For Marvell, investors continue to treat the stock as part of the broader AI infrastructure trade, where moves often track sentiment on data-center buildouts and connectivity spending.

Before the next session, traders will be looking for signs that the late-year pullback in big tech is stabilizing. The Dow fell 0.51% on Monday, the S&P 500 lost 0.35% and the Nasdaq dropped 0.5%, according to Reuters.

Minutes from the Federal Reserve’s previous meeting and weekly jobless claims are also on the radar in what Reuters described as an otherwise data-light week. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. Reuters

Marvell’s investor calendar lists a J.P. Morgan CES fireside chat with Chief Executive Matt Murphy on Jan. 6, but it does not yet show a date for the company’s next quarterly results.

Marvell is also promoting CES 2026 meetings in Las Vegas to showcase its copper and optical interconnect portfolio and CXL products; CXL, short for Compute Express Link, is a standard that helps servers connect processors and memory at high speed. Traders are also watching whether MRVL holds above $84, Monday’s low, and reclaims $86, the day’s high.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Next Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Go toTop